ESC Congress 2011

27 - 31 August 2011, Paris - France

Session Details

Poster session 6: Transcatheter aortic valve implantation - clinical
Tue 30 Aug 14:00 - 18:00 Aortic valve disease Poster Session Posters - Poster Zone C

Abstract Slides/e-posters Video Report

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
14:00P4963Transcatheter aortic valve implantation: impaired kidney function is an important predictor for survival and quality of life. Results from the German aortic valve interventions registryStefan SACK (Muenchen, DE)
14:00P4964Role of inflammation and reactive oxygen species in Acute Kidney Injury (AKI) after Transcatheter Aortic Valve Implantation (TAVI)Rafal DWORAKOWSKI (Bromley, GB)
14:00P4965Incidence and outcome of Paravalvular Aortic Regurgitation (PAR) after transfemoral aortic valve implantation (TAVI)Polykarpos Christos PATSALIS (Essen, DE)
14:00P4966Transcatheter aortic valve implantation via direct aortic approach: initial clinical experience with this novel approachPak Hei CHAN (Hong Kong, HK)
14:00P4967Frequency and predictors of acute kidney injury, and its impact on outcome after transcatheter aortic valve implantationKatrin GEBAUER (Muenster, DE)
14:00P4968The burden of not treating patients with severe aortic stenosis: comparison of secondary care resource consumption in TAVI versus medical management cohort of 30 patients in a UK NHS settingMark COOK (Watford, GB)
14:00P4969Previous heart surgery does not influence the outcome of Transcatheter Aortic Valve Implantation (TAVI) patients: results of the German registry on TAVIMarkus KASEL (Muenchen, DE)
14:00P4970Quality of life dynamics after transcatheter aortic valve implantationMarkus KRANE (Munich, DE)
14:00P4971Non-responding to transcatheter aortic valve implantation: impact of mitral valve regurgitation and left atrial enlargement on symptomatic benefitMichael GOTZMANN (Dortmund, DE)
14:00P4972Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosisTo Be Announced
14:00P4973Hemodynamic results after TAVI: up to 3 years follow-up of 338 patients after corevalve implantationAnke OPITZ (Muenchen, DE)
14:00P4974Transcatheter aortic valve implantation: economic evaluation of the FRANCE (FRench Aortic National Corevalve and Edwards) registryTo Be Announced
14:00P4975Acute results and late outcomes of transcatheter aortic valve implantation according to the valve academic research consortium classification: results of the prospective single centre Rouen registryBogdan BORZ (Rouen, FR)
14:00P4976Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and 1-year clinical outcomeFrancesco SAIA (Bologna, IT)
14:00P4977One-year outcome of patients eligible to transcatheter aortic valve implantation according to actual treatmentBarbara BORDONI (Bologna, IT)
14:00P4978Transcatheter aortic valve implantation: 1 year follow-up and predictors of mortality. Data from a multi-centre real world registry.Ralf ZAHN (Gruenstadt, DE)
14:00P4979Transcatheter aortic valve implantation: a new therapeutic option in patients with degenerated aortic bioprostheses? Results from the German aortic valve interventions registryRalf ZAHN (Gruenstadt, DE)
14:00P4980Transcatheter aortic valve implantation versus balloon valvuloplasty - periprocedural outcome data from the German-TAVI RegistryRalph HEIN (Muenchen, DE)
14:00P4981Transcatheter aortic valve implantation in low-gradient aortic stenosis: results from the german transcatheter aortic interventions-registryAlexander LAUTEN (Jena, DE)
14:00P4982Transcatheter aortic valve implantation for severe symptomatic aortic stenosis: results in patients with porcelain aortaRalf ZAHN (Gruenstadt, DE)
14:00P4983Antithrombotic therapy after transfemoral aortic valve implantation (TAVI). Potential hazard of triple-therapy.Uwe ZEYMER (Ludwigshafen, DE)
14:00P4984Incidence of corevalve dislocation - a single-center experienceFadi AL-RASHID (Essen, DE)
14:00P4985Patient prosthesis mismatch after transfemoral TAVI: survival in 12 month follow upBjoern PLICHT (Essen, DE)
14:00P4986Learning curve of transcatheter aortic valve implantation: trends in mortality over the yearsPablo SALINAS (Madrid, ES)
14:00P4987Prosthesis performance and outcome of transcatheter aortic valve implantation: a single center experience.Valeria GASPARETTO (Padova, IT)
14:00P4988Bleeding risk factors in transcatheter aortic valve implantation (TAVI) patientsJanina STEPINSKA (Warsaw, PL)
14:00P4989Periprocedural bleeding predicts outcome after transcatheter aortic valve implantation (TAVI)Brian HALLIDAY (London, GB)
14:00P4990Conduction abnormalities after balloon valvuloplasty predict permanent pacemaker requirement in transcatheter aortic valve implantationDaniel JOHN (Bergisch Gladbach, DE)
14:00P4991Invasive assessment of atrioventricular conduction changes following transcatheter aortic valve implantation with self-expandable or balloon-expandable prosthesisAnne GARDERES (Toulouse, FR)
14:00P4992Gender differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosisKentaro HAYASHIDA (Tokyo, JP)
14:00P4993Success of transcatheter aortic valve implantation (TAVI) according to standardized outcome definitions by the valve academic research consortium (VARC)Barbara STAEHLI (Zurich, CH)
14:00P4994Transcatheter aortic valve implantation with the Edwards valve prosthesis in patients with low (<20%) logistic euroscore: results of a prospective single center registryMatthieu GODIN (Rouen, FR)
14:00P4995Impact of mitral regurgitation on outcome of transcatheter aortic valve implantationAugusto D'ONOFRIO (Padova, IT)
14:00P4996Impact of prosthesis-patient mismatch on hemodynamic and clinical outcomes after transcatheter aortic valve implantation with balloon-expandable valvesSee Hooi EWE (Singapore, SG)
14:00P4997Numerous patients fail the aortic annulus criteria in transcatheter aortic valve implantation - comparison of current devicesDaniel JOHN (Bergisch Gladbach, DE)